Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo (Q40948527)
Jump to navigation
Jump to search
scientific article published on 12 February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo |
scientific article published on 12 February 2015 |
Statements
1 reference
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo (English)
1 reference
Rhonda Bentley-Lewis
Matthew C Riddle
Brian Claggett
Rafael Diaz
Peter Johnston
Lars V Køber
Francesca Lawson
Eldrin F Lewis
Lin Ping
Jeffrey L Probstfield
Scott D Solomon
Yujun Wu
Marc A Pfeffer
ELIXA Investigators
Kenneth Dickstein
12 February 2015
1 reference